The absence of erectile dysfunction from the official side effect profile suggests that if such a connection exists, it would be extremely rare or potentially related to other factors rather than the medication itself
One important change is that they state, GLP-1 RA therapy may be continued preoperatively in patients without elevated risk of delayed gastric emptying. The risk factors they state include: escalation phase of dosing, higher dose, weekly dosing (as opposed to daily dosing), gastrointestinal symptoms (nausea, vomiting, abdominal pain, dyspepsia, constipation), and medical conditions that may cause delayed gastric emptying
Use of the Prescription Registry [18] yielded continuous, complete and detailed information on use of the study drugs and other drug use over a period of more than 20 years
If you're not comfortable at 12mg, drop to 9mg